Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devang Shah

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Bacteriology|December 4, 2004
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coliIris Keren, Devang Shah, Amy Spoering, et al.
Bioanalysis|February 6, 2016
Absolute quantification of imipramine and its metabolites in vivo utilizing calibrators from radiolabeled in vitro incubationsPriyadeep Bhutani, Devang Shah, Ninad Varkhede, et al.
BMC Microbiology|June 14, 2006
Persisters: a distinct physiological state of E. coliDevang Shah, Zhigang Zhang, Arkady Khodursky, et al.
Journal of Nanoscience and Nanotechnology|September 16, 2015
Polyethylene Sebacate-Silymarin Nanoparticles with Enhanced Hepatoprotective ActivitySwati A Guhagarkar, Devang Shah, Mitesh D Patel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 12, 2015
Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimizationAjay Saxena, Devang Shah, Shweta Padmanabhan, et al.
Drug Metabolism Letters|November 28, 2014
A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 modelDevang Shah, Sundeep Paruchury, Muralikrishna Matta, et al.
Pharmaceutical Research|July 31, 2023
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug InteractionsJessica Chu, Erika Panfen, Linna Wang, et al.
Journal of Medicinal Chemistry|May 14, 2021
Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 InhibitorsLi Xu, Richard A Hartz, Brett R Beno, et al.
Journal of Medicinal Chemistry|March 23, 2023
Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-<i>b</i>]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) InhibitorsRichard A Hartz, Vijay T Ahuja, Prasanna Sivaprakasam, et al.
Journal of Medicinal Chemistry|August 5, 2024
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3<i>H</i>-1,2,4-triazole-3-thioneDavid S Yoon, Chunjian Liu, Prasada Rao Jalagam, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Bacteriology|December 4, 2004
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coliIris Keren, Devang Shah, Amy Spoering, et al.
Bioanalysis|February 6, 2016
Absolute quantification of imipramine and its metabolites in vivo utilizing calibrators from radiolabeled in vitro incubationsPriyadeep Bhutani, Devang Shah, Ninad Varkhede, et al.
BMC Microbiology|June 14, 2006
Persisters: a distinct physiological state of E. coliDevang Shah, Zhigang Zhang, Arkady Khodursky, et al.
Journal of Nanoscience and Nanotechnology|September 16, 2015
Polyethylene Sebacate-Silymarin Nanoparticles with Enhanced Hepatoprotective ActivitySwati A Guhagarkar, Devang Shah, Mitesh D Patel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 12, 2015
Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimizationAjay Saxena, Devang Shah, Shweta Padmanabhan, et al.
Drug Metabolism Letters|November 28, 2014
A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 modelDevang Shah, Sundeep Paruchury, Muralikrishna Matta, et al.
Pharmaceutical Research|July 31, 2023
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug InteractionsJessica Chu, Erika Panfen, Linna Wang, et al.
Journal of Medicinal Chemistry|May 14, 2021
Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 InhibitorsLi Xu, Richard A Hartz, Brett R Beno, et al.
Journal of Medicinal Chemistry|March 23, 2023
Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-<i>b</i>]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) InhibitorsRichard A Hartz, Vijay T Ahuja, Prasanna Sivaprakasam, et al.
Journal of Medicinal Chemistry|August 5, 2024
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3<i>H</i>-1,2,4-triazole-3-thioneDavid S Yoon, Chunjian Liu, Prasada Rao Jalagam, et al.
Pageof 2